Innovative Discovery Platform OmniAb's cutting-edge antibody discovery platform, which offers diverse repertoires and high-throughput screening tools, presents significant opportunities to collaborate on next-generation therapeutic development for pharmaceutical partners.
Recent Program Launches The company's launch of tools like the Partner Access Program for xPloration and OmniDeep indicates a readiness to expand collaborative research and licensing opportunities with biotech and pharma companies seeking advanced antibody engineering solutions.
Strategic Collaborations Partnerships with biotech firms like Veraxa Biotech for bispecific antibody-drug conjugates demonstrate OmniAb's potential as a key technology provider for innovative cancer therapies, opening avenues for strategic product development collaborations.
Market Engagement Active participation in prominent industry events such as PEGS Boston and the H.C. Wainwright Global Investment Conference signals OmniAb's focus on building relationships with investors and clients, creating potential touchpoints for business development.
Financial Position With a revenue range of 25 to 50 million dollars and ongoing funding of 30 million dollars, OmniAb is positioned as a growth-stage biotech with the capacity to invest in new projects and expand its partnership network to accelerate commercial adoption.
$1M$10M
$10M$25M
$250M$500M
$50M$100M
$25M$50M
$1M$10M
$10M$25M
$50M$100M
$25M$50MOmniAb, Inc. uses 8 technology products and services including Varnish, RSS, Webpack, and more. Explore OmniAb, Inc.'s tech stack below.
| OmniAb, Inc. Email Formats | Percentage |
| FLast@omniab.com | 47% |
| First@omniab.com | 5% |
| First.Last@omniab.com | 1% |
| FLast@omniab.com | 47% |
Biotechnology ResearchCalifornia, United States51-200 Employees
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
Company Overview
Media & News
Funding & FinancialsOmniAb, Inc. has raised a total of $30M of funding over 3 rounds. Their latest funding round was raised on Aug 25, 2025 in the amount of $30M.
OmniAb, Inc.'s revenue is estimated to be in the range of $25M$50M
Funding & FinancialsOmniAb, Inc. has raised a total of $30M of funding over 3 rounds. Their latest funding round was raised on Aug 25, 2025 in the amount of $30M.
OmniAb, Inc.'s revenue is estimated to be in the range of $25M$50M
1-888-653-2347 
support@leadiq.com